SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-020005
Filing Date
2018-08-07
Accepted
2018-08-07 16:51:29
Documents
3
Period of Report
2018-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180807.htm 8-K 30333
2 EX-99.1 xene-ex991_6.htm EX-99.1 234281
3 GRAPHIC gpkrjgohprio000001.jpg GRAPHIC 13001
  Complete submission text file 0001564590-18-020005.txt   283778
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 18998788
SIC: 2834 Pharmaceutical Preparations